Title | Drug Development and Industrial Pharmacy |
Abbreviation | Drug Dev. Ind. Pharm. |
Publication Type | Journal |
Subject Area, Categories, Scope | Organic Chemistry (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3) |
h-index | 100 |
Overall Rank/Ranking | 11307 |
SCImago Journal Rank (SJR) | 0.475 |
Impact Score | 2.31 |
Publisher | Informa Healthcare |
Country | United States |
ISSN | 03639045, 15205762 |
Best Quartile | Q2 |
Coverage History | 1974, 1976-2023 |
The topics primarily considered for the journal include:
- Emerging technologies in pharmaceutical development and industrial pharmacy
- In vitro-In vivo correlations
- Oral controlled release systems
- Drug delivery (oral, inhalation, injectable, buccal, etc)
- Preclinical drug development, pharmacokinetics and pharmacodynamics
- Drug pharmacokinetics and pharmacodynamics
- Biopharmaceutics and oral absorption
- Aerosols
- Transdermals
- Preformulation and physical pharmacy
- Methodologies, including statistical design/optimisation, if there is clear clinical relevance.
Drug Development and Industrial Pharmacy is a journal covering the technologies/fields/categories related to Organic Chemistry (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3). It is published by Informa Healthcare. The overall rank of Drug Development and Industrial Pharmacy is 11307. According to SCImago Journal Rank (SJR), this journal is ranked 0.475. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 100. The best quartile for this journal is Q2.
The ISSN of Drug Development and Industrial Pharmacy journal is 03639045, 15205762. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Development and Industrial Pharmacy is cited by a total of 1412 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Drug Development and Industrial Pharmacy is 2.31, which is computed in 2024 as per its definition. Drug Development and Industrial Pharmacy IF is decreased by a factor of 0.88 and approximate percentage change is -27.59% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Drug Development and Industrial Pharmacy is 2.31. If the same downward trend persists, Impact IF may fall in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 2.31 |
2022 | 3.19 |
2021 | 3.60 |
2020 | 3.14 |
2019 | 2.59 |
2018 | 2.44 |
2017 | 1.95 |
2016 | 2.25 |
2015 | 2.20 |
2014 | 2.09 |
Drug Development and Industrial Pharmacy has an h-index of 100. It means 100 articles of this journal have more than 100 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drug Development and Industrial Pharmacy is 03639045, 15205762. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drug Development and Industrial Pharmacy is 11307. According to SCImago Journal Rank (SJR), this journal is ranked 0.475. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.475 |
2022 | 0.474 |
2021 | 0.566 |
2020 | 0.628 |
2019 | 0.521 |
2018 | 0.608 |
2017 | 0.519 |
2016 | 0.686 |
2015 | 0.672 |
2014 | 0.783 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 11307 |
2022 | 10821 |
2021 | 8810 |
2020 | 8032 |
2019 | 9429 |
2018 | 7927 |
2017 | 8961 |
2016 | 6896 |
2015 | 7065 |
2014 | 5859 |
Drug Development and Industrial Pharmacy is published by Informa Healthcare. It's publishing house is located in United States. Coverage history of this journal is as following: 1974, 1976-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drug Development and Industrial Pharmacy is Drug Dev. Ind. Pharm.. This abbreviation ('Drug Dev. Ind. Pharm.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Organic Chemistry (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drug Development and Industrial Pharmacy latest impact IF is 2.31. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.60 (2021) and 1.95 (2017), respectively, in the last 10 years. Moreover, its average IS is 2.58 in the previous 10 years.
The Drug Development and Industrial Pharmacy has an SJR (SCImago Journal Rank) of 0.475, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.783 in 2014 and the lowest being 0.474 in 2022. Furthermore, the average SJR of the Drug Development and Industrial Pharmacy over the previous 10-year period stands at 2.58.
The latest h-index of the Drug Development and Industrial Pharmacy is 100.
The Drug Development and Industrial Pharmacy is published by the Informa Healthcare, with its country of publication being the United States.
The Drug Development and Industrial Pharmacy is currently ranked 11307 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 5859 in 2014 and its lowest position of 11307 in 2023.
The standard ISO4 abbreviation for the Drug Development and Industrial Pharmacy is Drug Dev. Ind. Pharm..
Drug Development and Industrial Pharmacy is classified as a journal that the Informa Healthcare publishes.
The Drug Development and Industrial Pharmacy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drug Development and Industrial Pharmacy is assigned the following International Standard Serial Numbers (ISSN): 03639045, 15205762.
The best quartile for the Drug Development and Industrial Pharmacy is Q2 (2023).
The Drug Development and Industrial Pharmacy coverage history can be summarized as follows: 1974, 1976-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
Discourse | journal | 6196 | Routledge | 65 | 2.36 |
Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
Sapporo Medical Journal | journal | 27142 | 3 | 0.00 | |
Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
Oral Radiology | journal | 8912 | Springer Japan | 23 | 2.13 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 2.31 |
2022 | 3.19 |
2021 | 3.60 |
2020 | 3.14 |
2019 | 2.59 |
2018 | 2.44 |
2017 | 1.95 |
2016 | 2.25 |
2015 | 2.20 |
2014 | 2.09 |